Glutathione

Glutathione in the Published Literature

UKPWritten and published by UK Peptides2 min readUpdated 4 cited sources

The short answer

Glutathione has one of the largest literatures of any compound in this catalogue: decades of biochemistry, randomised supplementation trials, and systematic reviews published as recently as 2025. The volume is a navigation problem rather than a scarcity problem.

Key facts

Literature size
Very large (decades of work)
Randomised trial
Richie 2015, Eur J Nutr
Systematic reviews
Two in 2025
Biochemistry
Extensively characterised
Contested area
Oral bioavailability
Compare
DSIP has ~519 records; this is larger

An unusual position for this catalogue

Most compounds here have thin literatures: KPV around 34 records, Selank 135. Glutathione is at the opposite extreme, a molecule central to cell biology, studied for decades, with its biochemistry largely settled. The uncertainty here is not about what it does in cells but about what supplementing it accomplishes.

Three distinct bodies of work

The core biochemistry (synthesis, redox cycling, enzyme systems), which is well established and not seriously disputed. The supplementation literature, including Richie's 2015 randomised trial, which is smaller and contested. And the cosmetic literature, reviewed systematically twice in 2025. These are different questions with different evidence quality, and conflating them is the usual error.

Research material referenced

Glutathione 1500mg, third-party HPLC tested

Buy Glutathione · £38.99

Why volume is not the same as resolution

A vast literature on cellular glutathione biochemistry says nothing about whether taking glutathione raises it. The settled part and the contested part concern different things. This is the same distinction that matters for NAD+, where the metabolic biochemistry is textbook material and the supplementation question is open.

Searching it

Glutathione alone returns an unmanageable volume. Pair it with the specific question (supplementation, bioavailability, skin, gamma-glutamyl) to reach anything useful. For the chemistry, PubChem under CID 124886 for GSH and CID 65359 for GSSG.

What is still open

Whether oral supplementation raises intracellular glutathione by absorption or by degradation and resynthesis. Whether raising it produces any outcome. And in the cosmetic literature, both efficacy and the safety of intravenous administration, which two independent 2025 reviews found worth examining.

Frequently asked questions

Is glutathione well studied?

Very. It is one of the most-studied small molecules in cell biology, and its core biochemistry is settled.

So why is anything contested?

Because the settled part is what glutathione does inside cells, and the contested part is what supplementing it accomplishes. Different questions.

Where should I start?

PubChem CID 124886 for chemistry, Richie 2015 for the supplementation question, and the 2025 systematic reviews for the cosmetic literature.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Glutathione articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.